Our study demonstrates that the results of Panama-FC in children with pulmonary hypertension, similar to WHO-FC, well reflect disease advancement confirmed by other non-invasive biomarkers: 6MWD, TAPSE, and NTproBNP which are unquestioned prognostic factors in this disease [5, 6]. Here, NPPB is linked to pulmonary arterial hypertension.